Why the Future of HealthTech lies in Integrated (and Hybrid) Primary Care

1. The Introduction: The Healthcare Paradox

The demographics of Italy and Europe paint a stark picture: we are facing a perfect storm. On one hand, an ageing population is driving up the demand for care; on the other, a structural shortage of General Practitioners (GPs) threatens to leave millions of citizens without a primary medical point of contact by 2030.

The National Health System (SSN), the pillar of our welfare state, is under immense pressure. Yet, while public debate often fixates on resources, as investors, we are observing a subtler but more radical shift: the evolution of demand. People—and companies—are no longer seeking mere symptom management. They are looking for integrated health: a journey that combines general medicine, mental wellbeing, prevention, and nutrition.

This is the moment HealthTech ceases to be a niche and becomes a fundamental asset class. But be warned: the days of simple booking apps or standalone video consultations are behind us.

2. Our Thesis: Solving the Fragmentation Puzzle

Our investment thesis for the HealthTech sector stems from a key observation: the primary issue with modern healthcare is not just a lack of resources, but the fragmentation of the patient experience .

Today, patients must navigate an obstacle course: specialists who don’t communicate, scattered clinical data, and bureaucracy that delays access to care. For P101, the real value lies in technological solutions capable of flipping this paradigm, moving from a “siloed” logic to a truly patient-centric approach.

We are not interested in merely digitising existing processes (such as the basic video visit). We are looking for platforms that act as “orchestrators”: intelligent systems that use data to centralise the patient journey, ensuring continuity of care. Technology thus becomes the connective tissue uniting prevention, acute care, and monitoring, making the system more efficient, accessible, and scalable.

Investing in HealthTech today means betting on models that integrate different dimensions of health (physical, mental, nutritional) into a single, coherent flow, breaking down the barriers that currently separate clinical disciplines.

3. From Theory to Practice: The Carol Case

It is within this precise theoretical framework that our renewed investment in Carol sits. We chose to continue supporting the company in this new funding round not just because of its growth metrics, but because Carol is the exact embodiment of our thesis on “integrated health”.

Carol turns this theory into a working product:

• Overcoming Fragmentation: It is not just a medical service, but a true “Full-Stack Clinic”. Thanks to the acquisitions of Mindwork and Welfood, it unites primary care, psychotherapy, and nutrition on a single platform.
• Institutional Credibility: It is the first virtual clinic fully authorised to operate, bridging the gap between digital innovation and the rigour of the National Health System.
• Scalability via Welfare: It has validated the market by bringing healthcare directly into the workplace, answering a concrete need for corporate efficiency and organisational wellbeing.

With Carol, our vision of a connected and accessible healthcare ecosystem becomes an operational reality. We are rebuilding continuity of care, powered by data.